Aripiprazole plus divalproex for recently manic or mixed patients with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind maintenance trial (Q48793990)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Aripiprazole plus divalproex for recently manic or mixed patients with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind maintenance trial	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22134973

Aripiprazole plus divalproex for recently manic or mixed patients with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind maintenance trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22134973

1 reference

based on heuristic

inferred from title

bipolar I disorder

1 reference

based on heuristic

inferred from title

5

object named as

Bo-Hyun Yoon

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22134973

2

object named as

Won-Myong Bahk

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22134973

1

object named as

Young Sup Woo

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22134973

10

object named as

Kwang Heun Lee

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22134973

Sang-Keun Chung

8

object named as

Sang-Keun Chung

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22134973

7

object named as

Yong Min Ahn

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22134973

9

object named as

Jeong-Gee Kim

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22134973

author name string

Moon Yong Chung

3

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22134973

Do-Hoon Kim

4

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22134973

Jong Hun Lee

6

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22134973

Ki-Chung Paik

11

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22134973

publication date

2 December 2011

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22134973

Human Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22134973

26

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22134973

8

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22134973

543-553

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22134973

A rating scale for drug-induced akathisia

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1240

21 January 2018

A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1240

21 January 2018

Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind trial

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1240

21 January 2018

Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1240

21 January 2018

Relapse and impairment in bipolar disorder

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1240

21 January 2018

The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1240

21 January 2018

A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1240

21 January 2018

Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1240

21 January 2018

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1240

21 January 2018

Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1240

21 January 2018

Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127).

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1240

21 January 2018

Maintenance of response following stabilization of mixed index episodes with olanzapine monotherapy in a randomized, double-blind, placebo-controlled study of bipolar 1 disorder

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1240

21 January 2018

Reversible elevation of triglycerides in dual-diagnosis patients taking aripiprazole: a case series

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1240

21 January 2018

Weight gain in bipolar disorder: pharmacological treatment as a contributing factor.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1240

21 January 2018

Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1240

21 January 2018

A rating scale for mania: reliability, validity and sensitivity

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1240

21 January 2018

Course and outcome in bipolar affective disorder: a longitudinal follow-up study

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1240

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1240

7 January 2021

based on heuristic

inferred from DOI database lookup

Twelve-month outcome after a first hospitalization for affective psychosis

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1240

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome in Mania. A 4-year prospective follow-up of 75 patients utilizing survival analysis

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1240

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HUP.1240

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22134973

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/22134973

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48793990&oldid=2210693130"